A close relationship between
tumor angiogenesis, growth, and
carcinomatosis has been observed. Netrin-4 (NT-4) has been shown to regulate angiogenic responses. We aimed to examine the effects of
NT-4 on colon
tumor angiogenesis, growth, and
carcinomatosis. We showed that
NT-4 was expressed in human
colon cancer cells (LS174). A 20-fold increase in
NT-4 expression was stably induced by
NT-4 pcDNA in LS174 cells. In vivo, a
Matrigel angiogenesis assay showed that
NT-4 overexpression altered
vascular endothelial growth factor (
VEGF)/
basic fibroblast growth factor-induced angiogenesis. In nude mice with LS174 xenografts,
NT-4 overexpression inhibited
tumor angiogenesis and growth. In addition, these NT-4-involved inhibitory effects were associated with decreased
tumor cell proliferation and increased
tumor cell apoptosis. Using an orthotopic
peritoneal carcinomatosis model, we demonstrated that
NT-4 overexpression decreased
colorectal cancer carcinomatosis. Moreover,
carcinomatosis-related
ascites formation was significantly decreased in mice transplanted with
NT-4 LS174 cells versus control LS174 cells. The antiangiogenic activity of
NT-4 was probably mediated by binding to its receptor
neogenin. Netrin-4 had a direct effect on neither in vitro apoptosis and proliferation of cultured LS174 cells nor the
VEGF-induced acute increase in vascular permeability in vivo. We propose that
NT-4 overexpression decreases
tumor growth and
carcinomatosis, probably via an antiangiogenic effect, underlying the potential therapeutic interest in
NT-4 in the treatment of
colorectal cancer growth and
carcinomatosis.